云南出台中药饮片专项资金管理办法:5亿资金重点扶持7大领域

2018-05-23 许晓锐 中国中医

日前,云南省工业和信息化委员会和财政厅联合印发《云南省中药饮片产业发展专项资金管理办法》,围绕打造中药材龙头加工企业种植养殖基地、中药饮片和中药材精深生产加工、中医药服务全产业链体系建设等,针对制约产业发展突出环节、重点领域、重点项目给予集中扶持,推进全省中药饮片产业发展。

日前,云南省工业和信息化委员会和财政厅联合印发《云南省中药饮片产业发展专项资金管理办法》,围绕打造中药材龙头加工企业种植养殖基地、中药饮片和中药材精深生产加工、中医药服务全产业链体系建设等,针对制约产业发展突出环节、重点领域、重点项目给予集中扶持,推进全省中药饮片产业发展。

今年4月,云南省政府出台《关于推进中药饮片产业发展的若干意见》,提出2018-2020年,省政府每年统筹安排奖补专项资金5亿元,支持中药饮片产业发展,引导社会资金投入。

《办法》明确,该省专项资金重点支持的领域包括中药材龙头加工企业育种、种植养殖基地建设;中药饮片(含新型中药饮片)、中药材精深生产加工项目;技术创新与智能制造;标准体系建设;打造一流平台,加大科研检验能力建设等7大领域。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1955893, encodeId=5011195589396, content=<a href='/topic/show?id=82e6e602651' target=_blank style='color:#2F92EE;'>#管理办法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76026, encryptionId=82e6e602651, topicName=管理办法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Thu Feb 14 03:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814695, encodeId=eeba181469511, content=<a href='/topic/show?id=d0f19589033' target=_blank style='color:#2F92EE;'>#重点扶持#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95890, encryptionId=d0f19589033, topicName=重点扶持)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Wed Oct 03 20:43:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322969, encodeId=ee24322969c5, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sun Jun 10 07:37:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476491, encodeId=f06414e64913a, content=<a href='/topic/show?id=e50422525f6' target=_blank style='color:#2F92EE;'>#中药饮片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22525, encryptionId=e50422525f6, topicName=中药饮片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e11d7287409, createdName=xiay994455, createdTime=Thu May 24 23:43:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318094, encodeId=ae223180947e, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 24 08:02:55 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1955893, encodeId=5011195589396, content=<a href='/topic/show?id=82e6e602651' target=_blank style='color:#2F92EE;'>#管理办法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76026, encryptionId=82e6e602651, topicName=管理办法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Thu Feb 14 03:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814695, encodeId=eeba181469511, content=<a href='/topic/show?id=d0f19589033' target=_blank style='color:#2F92EE;'>#重点扶持#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95890, encryptionId=d0f19589033, topicName=重点扶持)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Wed Oct 03 20:43:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322969, encodeId=ee24322969c5, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sun Jun 10 07:37:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476491, encodeId=f06414e64913a, content=<a href='/topic/show?id=e50422525f6' target=_blank style='color:#2F92EE;'>#中药饮片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22525, encryptionId=e50422525f6, topicName=中药饮片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e11d7287409, createdName=xiay994455, createdTime=Thu May 24 23:43:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318094, encodeId=ae223180947e, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 24 08:02:55 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1955893, encodeId=5011195589396, content=<a href='/topic/show?id=82e6e602651' target=_blank style='color:#2F92EE;'>#管理办法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76026, encryptionId=82e6e602651, topicName=管理办法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Thu Feb 14 03:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814695, encodeId=eeba181469511, content=<a href='/topic/show?id=d0f19589033' target=_blank style='color:#2F92EE;'>#重点扶持#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95890, encryptionId=d0f19589033, topicName=重点扶持)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Wed Oct 03 20:43:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322969, encodeId=ee24322969c5, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sun Jun 10 07:37:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476491, encodeId=f06414e64913a, content=<a href='/topic/show?id=e50422525f6' target=_blank style='color:#2F92EE;'>#中药饮片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22525, encryptionId=e50422525f6, topicName=中药饮片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e11d7287409, createdName=xiay994455, createdTime=Thu May 24 23:43:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318094, encodeId=ae223180947e, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 24 08:02:55 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
    2018-06-10 执着追梦

    学习.谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1955893, encodeId=5011195589396, content=<a href='/topic/show?id=82e6e602651' target=_blank style='color:#2F92EE;'>#管理办法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76026, encryptionId=82e6e602651, topicName=管理办法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Thu Feb 14 03:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814695, encodeId=eeba181469511, content=<a href='/topic/show?id=d0f19589033' target=_blank style='color:#2F92EE;'>#重点扶持#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95890, encryptionId=d0f19589033, topicName=重点扶持)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Wed Oct 03 20:43:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322969, encodeId=ee24322969c5, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sun Jun 10 07:37:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476491, encodeId=f06414e64913a, content=<a href='/topic/show?id=e50422525f6' target=_blank style='color:#2F92EE;'>#中药饮片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22525, encryptionId=e50422525f6, topicName=中药饮片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e11d7287409, createdName=xiay994455, createdTime=Thu May 24 23:43:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318094, encodeId=ae223180947e, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 24 08:02:55 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1955893, encodeId=5011195589396, content=<a href='/topic/show?id=82e6e602651' target=_blank style='color:#2F92EE;'>#管理办法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76026, encryptionId=82e6e602651, topicName=管理办法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Thu Feb 14 03:43:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814695, encodeId=eeba181469511, content=<a href='/topic/show?id=d0f19589033' target=_blank style='color:#2F92EE;'>#重点扶持#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95890, encryptionId=d0f19589033, topicName=重点扶持)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Wed Oct 03 20:43:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322969, encodeId=ee24322969c5, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sun Jun 10 07:37:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476491, encodeId=f06414e64913a, content=<a href='/topic/show?id=e50422525f6' target=_blank style='color:#2F92EE;'>#中药饮片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22525, encryptionId=e50422525f6, topicName=中药饮片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e11d7287409, createdName=xiay994455, createdTime=Thu May 24 23:43:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318094, encodeId=ae223180947e, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 24 08:02:55 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
    2018-05-24 执着追梦

    学习.谢谢分享

    0

相关资讯

云南力推“农村便民药柜”

日前,云南省食品药品监管局印发的《云南省设置“农村便民药柜”工作实施方案》(以下简称《方案》)明确,将在全省农村地区推动设置“农村便民药柜”,切实解决偏远农村地区群众“购药远、购药难、购药贵”的问题,打通农村药品供应“最后一公里”。

云南卫生计生委发布声明未开展确有专长相关培训

4月2日,云南省卫生计生委发布声明,云南省卫生计生委未委托任何机构开展中医医术确有专长人员医师资格考核注册管理、申报考核等相关培训班。

2020年 云南新增三甲医院13所

云南省政府新闻办提出到2020年和到2030年分两步走,实现每***6张床位、三甲医院13所等健康云南建设目标。

云南将停招中职农村医学专业

云南省人民政府办公厅在省政府网站上公布《关于深化医教协同进一步推进医学教育改革与发展的实施意见》,明确云南省高校大学招生逐步缩减现有中职层次农村医学、中医专业招生规模,2020年后逐步停止招生。

云南举办中医药健康旅游推进会:打开思路促进中医药健康旅游大发展

2018云南省中医药健康旅游工作推进会暨首期健康旅游融合发展项目实地游学专题交流会在昆明市举办。

云南66亿元投入健康扶贫

近日,云南省政府在昆明市举行《“健康云南2030”规划纲要》和《云南省“十三五”卫生与健康规划》政策解读新闻发布会。记者在会上获悉,到2020年,云南省各级财政累计将投入66亿元,进一步压紧压实健康扶贫各项优惠政策和兜底保障,全面实施县域内定点医疗机构先诊疗、后付费和一站式结算工作。